STDs
Aptitude Medical Systems Gets Gates Foundation Grant for At-Home STI Test
The funding will support development of a point-of-care and over-the-counter molecular diagnostic to detect chlamydia, gonorrhea, and trichomonas.
The Berlin, Germany-based firm said it plans to expand its test menu to take on many more infectious diseases with its portable molecular instrument.
Seegene Partners With Spanish Diagnostics Maker to Develop Syndromic qPCR Panels
The partners expect to jointly develop syndromic qPCR assays for sexually transmitted infections and antimicrobial resistance.
The firm plans to file for regulatory approval of its first test, a chemiluminescent ELISA for respiratory disease, as early as the first quarter of 2024.
POC Genotyping Tests Based on Electromagnetic Detection Tech Step out From Stanford University Lab
Premium
Spinout Magic LifeScience is leading commercialization of the molecular diagnostic technology, but the tests are popping up in other clinical scenarios, too.